Media Coverage: Project SG100K – DNA of 100,000 Singaporeans to be mapped to identify new ways to prevent diseases

27 May 2022

Precision Health Research, Singapore (PRECISE), the central entity implementing Singapore’s National Precision Medicine (NPM) strategy, and Illumina, Inc, a leader in genomics technology, announced a strategic partnership to sequence and analyse 100,000 Singaporean whole genomes (SG100K), to create for the first time, Southeast Asia’s most comprehensive consented population study.

Read more about the partnership via the media coverage below: